State of Wisconsin Investment Board
ORKA

State of Wisconsin Investment Board’s Oruka Therapeutics ORKA Stock Holding History

State of Wisconsin Investment Board’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$888K Sell
18,099
-4,869
-21% -$169K ﹤0.01% 1744
2025
Q4 		$696K Buy
+22,968
New +$640K ﹤0.01% 1800

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

State of Wisconsin Investment Board's ORKA Position: Q1 2026 in Review

State of Wisconsin Investment Board reduced its Oruka Therapeutics (ORKA) stake by 21% in Q1 2026, selling an estimated $169K and leaving 18,099 shares worth $888K. The position accounts for ﹤0.01% of the portfolio, ranked #1744.

State of Wisconsin Investment Board first reported a position in ORKA in Q4 2025 and has held it in 2 quarters since. 184 funds tracked by Wall St. Rank hold ORKA as of Q1 2026.

  • State of Wisconsin Investment Board held 18,099 shares of Oruka Therapeutics worth $888K as of Q1 2026.
  • State of Wisconsin Investment Board sold 4,869 Oruka Therapeutics shares in Q1 2026, an estimated $169K.
  • Oruka Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1744 holding.
  • State of Wisconsin Investment Board first reported a position in Oruka Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 184 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.